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The development of a new technology for the detection of doublestranded (ds) DNA enables multiple biomedical applications including identifying
multiple pathogens simultaneously. We previously employed colorimetric
SEquence-Enabled Reassembly with TEM-1 β-lacatamase (SEER-LAC) to
detect specific bacterial DNA sequence. SEER-Lac consists of the two inactive
β-lactamase fragments which of each attached to a zinc finger protein (ZFP)
would reassemble into an active full-length enzyme upon ZFPs binding to its
target DNA. Here, we engineered two pairs of ZFPs which of each recognizes
shiga toxin in E. coli O157 and staphylococcal enterotoxin B in Staphylococus
Aureus, respectively. Biotin was simply conjugated to the detection probe ZFP,
which allows for generating chemiluminescent signal in streptavidin-HRP
(Horseradish peroxidase) assay upon ZFPs binding to their target DNA. Our
assay generates DNA-dependent signal and allows for a detection limit of 0.5
nM without DNA amplification or DNA labeling. Our system can be developed
into a simple multiplexed detection diagnostic for multiplexed detection of
dsDNA.

IX

INTRODUCTION
1.1 Zinc Finger Protein (ZFP)

Cys2-His2 zinc finger protein is one of the most common DNA- binding
domains1. Functions of ZFPs are extraordinarily versatile including DNA
recognition, drug discovery, RNA packaging, transcriptional regulation and
activation, regulation of apoptosis, protein folding and assembly, and lipid
binding 2. Here, we discuss DNA recognition and diverse applications of ZFPs.

1.2 DNA Recognition
Zinc ion is tetrahedrally coordinated of two cysteine and two histidine
residues (Figure 1.1). ZFPs form a ββα structure, stabilized by hydrophobic
interactions (Figure 1.1). Each zinc finger identifies three to four nucleotides of
DNA and can be assembled into a tandem array. Six zinc finger domains can
recognize 18 base pairs of desired DNA sequence

3.

There are naturally

occurring ZFPs such as zif268. Zinc finger domains can be engineered to be
used for diverse applications such as gene regulation and gene editing 4. The
specificity of zinc fingers is determined by the α-helix region, which is inserted
into the major groove of DNA where ZFPs contact 3 or 4 bases. Using phage
display technology, target sites contacting amino acids in the zinc finger domain
were randomized for the selection of new variants that recognize desired

DNA

sequences 3. This allowed the selection of ZF recognition modules to construct
multi-domain zinc fingers to bind to any desired DNA sequences

1

3

(a)

(b)

Figure 1.1
Structure of DNA-binding ZFPs and modular assembly of multi-finger proteins (a)
Image of zinc ion tetrahedrally coordinated with two cysteines and histidines 5.
(b) Modular assembly of three finger proteins 6.

2

1.3 ZFP application
In addition to its DNA recognition function, ZFPs have been known for a
number of its application in different scientific field from medical to gene editing 5.
As shown in Figure 1.2, DNA-binding ZFPs are linked to two inactive fragments
of Fok I nuclease, creating zinc finger nucleases (ZFNs). ZFNs yield DNA
cleavage in specific sequences, functioning as a target DNA cutter 7. One of the
first applications of engineered ZFPs was artificial modulators of gene
expression 5. For example, the first synthetic activator and repressor of a human
gene were created by conjugating engineered multilfinger ZFPs to a repeat
derived from the herpes simplex VP16 activation domain (VP64) and the
Kruppel-associated box (KRAB) repression domain, respectively 5. In gene
editing, ZFPs were fused with serine (Gln) recombinases to build an enzyme
that only catalyze integration or excision in a site-specific manner as shown in
Figure 1.2.

3

Figure 1.2
Versatile applications of ZFPs. 5.

4

2. Detection of DNA sequence
A sensitive detection of specific DNA sequence is of great interest and
demand for diagnostics and other biomedical applications. There are a number
of conventional methods which require denaturation and hybridization of target
double-stranded (ds) DNA which requires a few additional steps and is
considered as time-consuming 8. However, DNA- binding domains such as
ZFPs were discovered and developed to be another generation of direct
detection of DNA sequences 9.

2.1 Polymerase Chain Reaction (PCR)
The detection of pathogen-specific DNA or RNA via PCR or reverse
transcription-PCR addresses the issues of presence and viability without the
need for culturing the organism 8. In this respect, PCR-based methods offer a
distinct advantage for the detection of fastidious and non-cultivable organisms 8.
As successful identification depends on appropriately chosen primer sets, all
PCR-based testing requires a prior knowledge pertaining to the identity of the
organism

10.

Multiplex PCR enable us to amplify up to six unique diagnostic

regions for a single organism or identify nine different microorganisms within a
single experimental reaction 10.

2.2 DNA microarray
In DNA microarray, specific DNA oligonucleotides are immobilized in a 2dimension

(or

sometimes

3-dimension)
5

array

on

a

surface

through

covalent or non-covalent bonding. It has been widely used in gene expression
analysis,

transcription

factor

polymorphism (SNP) genotyping

binding
11.

assay,

and

single-

nucleotide-

Typically, a mixture of probe that is

complementary in sequence with a labeled target nucleic acid is hybridized with
single-stranded (ss) DNA target. The array is used to measure the relative
concentrations of the nucleic acid species in sample solution. Denaturation of ds
DNA is required, followed by hybridization which is considered as a timeconsuming process.
DNA microarray can develop its own sensitivity and sample capacity by
applying front-end target-specific nucleic acid amplification such as isothermal
Klenow fragment-based, DNA polymerase based, and multiplexed PCR

12,13.

The DNA microarray requires denaturation and subsequent hybridization
between target DNA and its complimentary probe. Specificity of DNA
hybridization comes from a random amplification approach that might inherently
generate nontargeted amplicons

12.

The combination of long oligonucleotide

probes, formamide-based hybridization buffers, and high-temperature posthybridization washes provided an acceptable means to control hybridization
specificity 12. In addition the signal measured at a given position on a microarray
is typically assumed to be proportional to the concentration of single species in
solution that can hybridize to that location. There are some drawbacks in this
method such as indirect measurement of target nucleic acid

14.

In particular, for

complex genomes such as mammalian genomes, it is often fastidious to design
microarrays in which multiple related nucleic acid sequences will not bind to the
6

same probe on the array, because a number of genes have sequence homology
among them 15.

2.3 SEquence-Enabled Reassembly (SEER)-LAC system
A number of methods for reading the sequence information of DNA such
as Enzyme-linked immunosorbent assay (ELISA), PCR, Sanger sequencing,
Southern and Northern blotting rely on the hybridization property of
complementary nucleic acid molecules

16.

Consequently, they require

denaturation of dsDNA into a single-stranded DNA, and subsequent
renaturation with specific primers or probes under controlled specific conditions.
However, direct detection of dsDNA can avoid the need for denaturation and
subsequent hybridization. Toward this end, a methodology for direct reading
information of dsDNA through interactions with ZFPs has been developed

17,18.

The SEER system consists of split β- lactamase protein systems that are able to
reassemble split fragments upon ZFP binding to a desired DNA sequence 18.

The SEER-LAC system utilizes protein complementation assays (PCA).
As shown in Figure 2.1, a full-length enzyme called a reporter molecule is split
into two inactive enzymatic fragments. Each split domain is attached to ZFPs.
Two inactive fragments were reassembled into a full- length enzyme when ZFPs
bind to the target DNA. Reassembled protein fragments will produce detectable
signals in a fluorescent, luminescent or colorimetric assay. This assay tests the
reproducibility of detection of protein-protein interactions in vivo and in vitro in
any cell type

19.

The correct assembly of the reporter molecule is dependent on
7

the recovery of both the structural geometry intrinsic to the reporter proteins and
of the complex formed by the interacting proteins. This is one of the major
distinctions of PCA assay compared with fluorescence resonance energy
transfer (FRET), bioluminescence resonance energy transfer (BRET), or yeast
two-hybrid assays. SEER-based methods with different reporter molecule
reassembly have been reported using β-galactosidase, TEM 1- β-lactamase,
and green fluorescent protein (GFP) 20,21.

8

Figure 2.1
Schematic diagram of the SEER-LAC system. A pair of ZFPs (Lac A-Zif 268 and
PBSII-Lac B) is linked to two inactive fragments of β-lactamase. In the presence
of the target DNA sequence, the two ZFPs bind to the target DNA and
reassembly of the two fragments of the enzyme occurrs18.

9

3. Detection methods for a DNA diagnostic
As the need for developing a sensitive and rapid target DNA detection
method increases, a number of studies of DNA detection methods have been
carried out. Here, different detection methods using both colorimetric and
chemiluminescent will be discussed, these methods were introduced to the
biomedical field with the hope of improving sensitivity and capability of
multiplexed detection.

3.1 Colorimetric detection
To achieve visual detection of target dsDNA, development of a
colorimetric detection method using ZFPs plays a crucial role in biomedical
research. As mentioned in 2.3, the SEER-LAC system is based on enzymatic
amplication of the reporter enzyme TEM-1 β-lactamase and nitrocefin, its
substrate is hydrolyzed by β-lactamase, generating a color change from yellow
to red. Therefore, one can detect the presence of the target pathogenic DNA in
a DNA-dose dependent signal. β-lactamase activity can be easily assayed by
the hydrolysis of nitrocefin, which changes from yellow to red (peak absorbance
at 486 nm) when the β- lactam ring is hydrolyzed by β-lactamase. This assay
can be performed both in solution and on a solid surface such as a poly
(ethylene glycol) (PEG) hydrogel coated slide

17.

In solution assay, ZFPs were

tagged with two inactive fragments (Lac A and LacB) of the 390-amino acid
TEM-1 β- lactamase protein which can be generated by splitting the protein
between residues 196 and 198 respectively

22.

To maintain the correct

orientation of the protein fragements, one ZFP was appended to the C
10

-terminus of β- lactamase residues 26-196 (LacA-ZFP; lacking the N-terminal
secretory signal sequence), and the other ZFP was appended to the N-terminus
of residues 198-290 (ZFP-LacB) 20.
To design a point-of-care (POC) system using ZFP, the SEER-LAC
system was also added to PEG hydrogel-coated slides17. In the work by Kim,et
al., the SEER-LAC system was applied to develop ZFP arrays that can function
as a simple device to detect bacterial ds DNA sequences

17.

ZFP (A) tagged

with Lac A was deposited on designated spots of a PEG hydrogel coated slide.
DsDNA containing target sites were applied onto the surface where the ZFP (A)
was deposited. The capture probe LacA- ZFP (A) binds to target DNA. After
washing steps to remove weakly and unbound dsDNA, the slide was air-dried
and the detection probe ZFP (B)- Lac B was applied to the slide. Another
washing step removed unbound molecules. In the presence of target bacterial
dsDNA, LacA and LacB would reassemble to form the full-length reporter
enzyme β- lactamase, thereby hydrolyzing the substrate. The color change from
yellow to red indicates the presence of target DNA 17.
3.2 Chemiluminescent detection
To achieve better sensitivity and lower limit of detection, there are
numerous transitions from colorimetric detection methods to chemiluminescent
detection methods

23.

Among a number of assays for detecting antigen and

nucleic acid, Chemiluminescence enzyme immunoassay (CLEIA) showed high
sensitivity

and

specificity

24.

It

has

been

widely

used

in

clinical and biomedical research due to advantages such as no radioactive
11

waste, relatively simple and inexpensive instrumentation, low detection limit, and
broad dynamic range. Chemiluminescent detection techniques commonly use
horseradish peroxidase (HRP) or alkaline phosphatases (ALPs) as a label for
enzyme immunoassay. These enzymes are labeled to the antibody or antigen
molecules. The chemiluminescent substrates undergo a peroxidase- catalyzed
oxidation in the presence of a suitable oxidant. After the immunological reaction,
the chemiluminesence intensity of the label is detected for the quantitative
analysis of antibody or antigen 25.
Streptavidin-HRP conjugate or avidin-HRP conjugate are commonly used
to react with its chemiluminescent substrate

26.

Both avidin and streptavidin

have a high affinity toward biotin which was chemically conjugated to detection
probe

27.

Two compounds (streptavidin and biotin) can then be linked

irreversibly with each other. The chemiluminescence is transduced from
enzymatic reaction between HRP and its substrate luminol with a help of a
stable peroxide solution

28.

Sensitive detection of target DNA by applying

chemiluminescent detection has been reported for the detection of human B19
DNA in human sera by using digoxigenin-labeled probes

24.

To establish the

sensitivity of chemiluminescence assay, digoxigenin-labeled target probe was
hybridized with dotted homologous DNA and was revealed by both
chemiluminescent

and

colorimetric

signal.

It

suggested

that

the

chemiluminescent dot blot hybridization assay can be considered to be a
sensitive and reliable method both for diagnostics and screening of samples in
the search of any target DNA 24.
12

MATERIALS AND METHODS
1. Chemicals and solutions

Bio-dot microfiltration device, nitrocellulose membrane, and Bio-dot SF filter
papers

were

purchased

from

Biorad

(Hercules,

CA).

Light

Shift

Chemiluminescent EMSA Kit, Streptavidin-Horseradish Peroxidase (SA- HRP)
conjugate, sulfosuccinimidyl-4-[N-maleimidomethyl] cyclohexane-1 carboxylate
(sulfo-SMCC), N-succinimidyl-S acetylthiopropionate (SATP), and EZ-link sulfoNHS-LC-LC-biotin were obtained from Thermo Scientific (Waltham, MA).
Chemiluminescent

substrates,

Supersignal West pico

chemiluminescent

substrate were purchased from Thermo scientific (Waltham, MA). Target dsDNA
was obtained from IDT (Integrated DNA Technology) (Coralville, IA). Tris buffer
containing Zn2+ (TZ buffer, pH 8.5) consisted of 100 mM tris, 90 mM KCl, 0.1
mM ZnCl2, and 1 mM MgCl2. HEPES buffer (pH 7.5) containing 100 mM 4-(2hydroxyethyl)-1- piperazineethanesulfonic acid, 90 mM KCl, 0.1 mM ZnCl2, and
1 mM MgCl2. Zinc Buffer A (ZBA) was made of 10 mM Tris, pH7.5, 90 mM KCl,
1 mM MgCl2, and 90 μM ZnCl2.
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Table 1. Sequence of DNA oligonucleotides
1.1 Target DNA
Stx2_233_268
SEB400_435

GAC GGC TTG ATG TCT ATC AGG CGC GTT TTG ACC ATC TTC
GGG TTTT CCC GAA GAT GGT CAA AAC GCG CCT GAT AGA CAT
CAA GCC GTC
GAC GGT GTG ACC GAG CAT GAT GGA AAT CAA ATA GAT AAA
CCC TTTT GGG TTT ACT TAT TTG ATT TCC ATC ATG CTC GGT
CAC ACC GTC

1.2 EMSA oligo
Stx2_233
Forward primer
Reverse primer

5’-/5Biosg/GCC GGC TTG ATG TCT ATC AGG GtG-3’
5’-TTT TTT TTT TTT TTT CAC CCT GAT AGA CAT CAA GCC GGC-3’

Stx2_268
Forward primer
Reverse primer

5’ -/5Biosg/GCC CGC GTT TTG ACC ATC TTC TCG-3’
5’-TTT TTT TTT TTT TTT CGA GAA GAT GGT CAA AAC GCG GGC-3’

Stx2_525
Forward primer
Reverse primer

5’ -/5Biosg/GCT TGC ATC CAG AGC AGT TCT GCG-3’
5’-TTT TTT TTT TTT TTT CGC AGA ACT GCT CTG GAT GCA AGC-3’

Stx2_560
Forward primer

5’-/5Biosg/GCTGCG TTT TGT CAC TGT CAC CTG-3’

Reverse primer

5’-TTT TTT TTT TTT TTT CAG GTG ACA GTG ACA AAA CGC AGC-3’

Stx2_1093
Forward primer
Reverse primer

5’-/5Biosg/GCT AAG TGG CCG GGA AAG AAT GCG-3’
5’-TTT TTT TTT TTT TTT CGC ATT CTT TCC CGG CCA CTT AGC-3’

Stx2_1128
Forward primer
Reverse primer

5’-/5Biosg /GAC ACT GGA CCA GTC GCT GGA GTG-3’
5’-TTT TTT TTT TTT TTT CAC TCC AGC GAC TGG TCC AGT GTC-3’

SEB 400
Forward primer
Reverse primer

5’- /5Biosg/CCA GGT GTG ACC GAG CAT GAT GtG-3’
5’-TTT TTT TTT TTT TTT CAC ATC ATG CTC GGT CAC ACC TGG-3’

SEB 435
Forward primer
Reverse primer

5’-/5Biosg/GCC GGA AAT CAA ATA GAT AAA GtG-3’
5’-TTT TTT TTT TTT TTT CAC TTT ATC TAT TTG ATT TCC GGC-3’

1.3 Primer
pMAL vector
Forward primer
Reverse primer

5’-GAC GCG CAG ACT AAT TCG AGC-3’
5’-CCT CTT CGC TAT TAC GCC AGC-3’

14

1. Construction, expression, and purification of ZFPs
Four pairs of ZFPs (stx2_233 and stx2_268, stx2_525 and stx2_560,
stx2_1093 and stx2_1128, SEB_400 and SEB_435) were used in this study,
which were designed to target a pathogenic strain of STEC (Shiga toxinproducing E.coli) and Staphylococus Aureus (Figure 2.2). Six finger protein
stx2_268 and SEB400 were capture probes and stx2_233 and SEB_435 were
detection probes. Each ZFP was constructed by the modular assembly method
using the Barbas set of modules in a modified Sp1C framework

29.

ZFPs

(stx2_233, stx2_268, stx2_525, stx2_560, stx2_1093, stx2_1128, SEB_400, and
SEB_435) were subcloned between the BamHI and HindIII sites of pMAL-c2X
full-length β-lactamase, replacing the full-length β-lactamase. The vector
enables bacterial expression of the proteins as fusions with an N-terminal
maltose binding protein (MBP) as a purification tag. Proteins were expressed in
E. coli BL21 (Invitrogen) upon induction with 0.3 mM Isopropyl b-D-1thiogalactopyranoside (IPTG) at an OD600 of 0.6–0.8 for 3h at 37 °C. Cells
were pelleted and resuspended in Zinc Buffer A (ZBA: 100 mM Tris base, 90
mM KCl, 1 mM MgCl2 and 100 mM ZnCl2 at pH 7.5) including 5 mM dithiothreitol
(DTT) and 50 mg/ml RNase A. After sonication, proteins in cell lysate were
applied to an amylose resin column (NEB) which was pre-equilibrated with ZBA
containing 5 mM DTT, washed with ZBA containing

2 M NaCl

and

ZBA

containing 1 mM tris(2- carboxyethyl)phosphine (TCEP), and eluted in ZBA
containing 10 Mm maltose and 1 mM TCEP. Concentration and purity were
assessed by Bradford assay and Coomassie-stained polyacrylamide gel
15

electrophoresis with sodium dodecyl sulfate (SDS-PAGE) using bovine serum
albumin (NEB) standards. A purified protein was stored in ZBA containing 1 mM
TCEP.

16

Figure 2.2 Nucleotide sequences of the seb and stx genes
Staphylococcus aureus seb gene for enterotoxin B, complete cds
GenBank: AB630021.1
1
61
121
181
241
301
361
421
481
541
601
661
721
781

atgtataata gattatttgt ttcacgtgta attttgatat tcgcactgat actagttatt
tatacaccca acgttttagc agaaagccaa ccagatccta aaccagatga gttgcacaaa
gcgagtaaat tcactggttt gatggaaaat atgaaagttt tatacgatga taatcatgta
tcagcaataa acgttaaatc tatagatcaa tttctatact ttgacttaat atattctatt
aaggacacta agttagggaa ttatgataat gttcgagtcg aatttaaaaa caaagattta
gctgataaat acaaagataa atacgtagat gtgtttggag ctaattatta ttatcaatgt
tatttttctg aaaaaacgaa tgatattaat tcacatcaaa ctgataaacg aaaaacttgt
atgtatggtg gtgtaactga gcataatgga aaccatttag ataaatatag aagtattact
gttagggtat ttgaagatgg taaaaattta ttgtcttttg acgtacaaac taataagaaa
aaagtgactg ctcaagaatt agattaccta actcgtcact atttggtgaa aaataaaaaa
ctctatgaat ttaacaactc accttatgaa acgggatata ttaaatttat agaaagtgag
aatagctttt ggtatgacat gatgcctgca ccaggagata aatttgacca atctaaatat
ttaatgatgt acaatgataa taaattggtt gattctaaag atgtgaagat tgaagtttat
cttacgacaa agaaaaagtg a

Target site 400-435 is highlighted.
Escherichia coli stx2A gene for shiga toxin 2A and stx2B gene for shiga toxin 2B
GenBank: FR850033.1

1 atgaagtgta tattatttaa atgggtactg tgcctgttac tgggtttttc ttcggtatcc
61 tattcccggg aatttacgat agacttttcg actcaacaaa gttatgtctc ttcgttaaat
121 agtatacgga cagagatatc gacccctctt gaacatatat ctcaggggac cacatcggtg
181 tctgttatta accacacccc accgggcagt tattttgctg tggatatacg agggcttgat
241 gtctatcagg cgcgttttga ccatcttcgt ctgattattg agcaaaataa tttatatgtg
301 gccgggttcg ttaatacggc aacaaatact ttctaccgtt tttcagattt tacacatata
361 tcagtgcccg atgtgacaac ggtttccatg acaacggaca gcagttatac cactctgcaa
421 cgtgtcgcag cgctggaacg ttccggaatg caaatcagtc gtcactcact ggtttcatca
481 tatctggcgt taatggagtt cagtggtaat acaatgacca gagatgcatc cagagcagtt
541 ctgcgttttg tcactgtcac agcagaagcc ttacgcttca ggcagataca gagagaattt
601 cgtcaggcac tgtctgaaac tgctcctgtg tatacgatga cgccgggaga tgtggacctc
661 actctgaact gggggcgaat cagcaatgtg cttccggagt atcggggaga ggatggtgtc
721 agagtgggga gaatatcctt taataatata tcagcgatac tgagtactgt ggccgttata
781 ctgaattgcc atcatcaggg ggcgcgttct gttcgcgccg tgaatgaaga gagtcaacca
841 gaatgtcaga taactggcga caggcccgtt ataaaaataa acaatacatt atgggaaagt
901 aatacagcag cagcgtttct gaacagaaag tcacagtttt tatatacaac gggtaaataa
961 aggagttaag tatgaagaag atgtttatgg cggttttatt tgcattagtt tctgttaatg
1021 caatggcggc ggattgcgct aaaggtaaaa ttgagttttc caagtataat gagaatgata
1081 cattcacagt aaaagtggcc gggaaagaat actggaccag tcgctggaat ctgcaaccgt
1141 tactgcaaag tgctcagctg acaggaatga ctgtcacaat caaatccagt
Acctgtgaat 1201 caggctccgg atttgctgaa gtgcagttta attttgaatga

Target sites 233-268, 525-560, and 1093-1128 are highlighted
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2. Electrophoretic Mobility Shift Assay (EMSA)
DNA-binding affinity of four pairs of ZFPs (stx2_233 and stx2_268,
stx2_525 and stx2_560, stx2_1093 and stx2_1128, SEB_400 and SEB_435) to
their target dsDNA was determined as a Kd value. Complementary pairs of
forward and reverse oligonucleotides (Table 1) were annealed to obtain target
dsDNAs. EMSA was performed according to the manufacturer’s protocol
(Thermo fisher). Binding reactions between ZFPs and target dsDNA were
performed for 1hr at room temperature and 30 min at 4°C in ZBA containing 150
mM KCl, 5 mM DTT, 10 % glycerol, 0.1 mg/ml BSA, 0.05 % NP-40, 0.25 nM
target DNA and puriﬁed ZFPs with a concentration of 0.025–1000 nM. Gel
electrophoresis was performed on a 10% native polyacrylamide gel in 0.5 X
TBE buffer. After blotting on a nylon membrane, the DNA was cross-linked by a
UV cross- linker for 4 min after 2 min pre-heating of the instrument. According to
the manufacturer’s protocol, the membrane was incubated in blocking buffer for
15 min and subsequently with SA-HRP conjugate for another 15min. The
membrane was washed for 5 times for 5 min with wash buffer in a gentle
rocking and incubated with substrate equilibration buffer for another 5 min. The
chemiluminescent signal was captured by CCD camera for 40 min after
exposing to Super Signal West Pico chemiluminescent substrate for 5 min.
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3. Chemical conjugation: Biotinlyation

The biotin-conjugated ZFP was obtained by cross-linking EZ-link sulfoNHS-LC-LC-biotin and the amine group of a MBP of the capture probe ZFP. 500
μL of HEPES buffer containing 200 μg/mL ZFP was mixed with 10 μL of 4 mM
EZ-link sulfo-NHS-LC-LC-biotin and incubated for 2 h at 4 °C, and the mixture
was then filtered by centrifugation for 20 min at 12,000 rpm. A detailed
calculation of obtaining 200 μg mL−1 detection probe ZFP is as follows.

X μΜ = (A μg μL−1 /65000) x 1000000
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ZFP concentration obtained from Bradford assay: X μΜ Target
ZFP concentration: 200 μg/mL
Size of MBP + ZPF protein: 65,000 Dalton

4. Microfiltration

The sequences of the ssDNA oligonucleotide used to form the target
dsDNA are provided in the Table 1. DNA target oligonucleotides were dissolved
in sterile nanopure water in a concentration of 250 μM and were heated at 95℃
for 10 min, then slowly cooled to room temperature to form hairpins containing a
four-thymidine loop. For further use, DNA was diluted in PBSTM (0.1% milk (w/v)
in PBST/Zn2+ buffer). ZFPs targeting different DNA oligonucleotides were
immobilized

on

the

nitrocellulose membrane (pore size, 0.45 μM) using a

microfiltration device (Biorad). The membrane was coated with different
concentrations of ZFP (A); SEB400 (100 nM, 150 nM, 200 nM, 400 nM, 800 nM,
and 1.6 μM) and stx2_268 (100 nM, 150 nM, 200 nM, 400 nM, 800 nM, and 1.6
μM) in different chamber wells by adjusting flow valve settings according to the
manufacturer’s manual. The ZFP (A)-coated membranes were washed twice
with PBST/Zn2+ buffer under vacuum, followed by blocking with
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1%

BSA in PBST/Zn2+ by gravity flow in the microfiltration device. Target DNA
oligonucleotides were applied onto the ZFP (A)-coated membrane by gravity
flow in the following concentration: SEB400_435 (0.5, 1, 5, 10, 50, 100, and
200 μM), Stx2_233_268 (0.5, 1, 5, 10, 50, 100, and 200 μM). After washing the
membrane twice with PBST/Zn2+, biotinylated ZFP (B)s SEB435 and Stx2_233
were applied to each well by gravity flow. The membranes were subsequently
washed twice with PBST/Zn2+ and treated with SA-HRP (1:500 dilution in
PBSTM) for 1 h at room temperature using a gentle rocking motion for the
detection of DNA product bound to the immobilized ZFPs. After washing with
PBST/Zn2+, the chemiluminescent signal was captured by a CCD camera after
exposure to Super Signal West Pico chemiluminescent substrate for 1 min. The
intensity of each dot was quantified using the NIH ImageJ program.
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RESULTS AND DISCUSSION
1. Cloning, expression, and purification of ZFPs
Two pairs of ZFPs (stx2_233 and stx2_268, SEB400 and SEB435) were
used in this study, which were engineered to detect a pathogenic strain of E. coli
O157 and S. aureus. ZFPs were constructed by the modular assembly method
utilizing the Barbas set of modules in a modified Sp1C framework 6. A pair of
ZFPs (stx2_233 and stx2_268) previously cloned was used for this study. ZFPs
(SEB400 and SEB435) were subcloned between the BamHI and HindIII sites of
pMAL-rrsA125, replacing the rrsA125 by double-digestion. Figure 3.1 shows the
DNA gel after 3 hr of double-digestion at BamHI and HindIII sites on pMAL_fullβ- Lactamase, pUCSp_SEB400, and pUC57_SEB435. The band indicating only
pMAL vector (size of 6.7 kb) was cut out from the gel and the linear DNA was
extracted using a QIAquick® Gel Extraction Kit. The band indicating six finger
ZFPs SEB400 and SEB435 (size of 540 bp) were identically treated as the
vector DNA. After obtaining linear DNA of the vector (pMAL) and the insert
(SEB400 and SEB435), both DNAs were ligated into a circular plasmid DNA to
be transformed into E. coli DH5α cell. To confirm whether ligation was properly
performed, PCR was performed on the only insert site using forward and
reverse pMAL primer (Table 1). Figure 3.2 depicts the colony PCR gel images of
both pMAL_SEB400 and pMAL_SEB435. Bands are shown at a size of 540
bp indicating ligated plasmid DNA. The plasmid DNA was transformed into E.
coli DH5α. The vector enables bacterial expression of the proteins as fusions
with an N- terminal maltose binding protein (MBP) as a purification tag. Proteins
22

were expressed in E. coli BL21. Concentration and purity were assessed by
Coomassie-stained polyacrylamide gel electrophoresis with sodium dodecyl
sulfate (SDS-PAGE) using BSA standards. Figure 3.3 shows image of the SDSPAGE gel of ZFPs (stx2_233, stx2_268, SEB400, and SEB435). The purified
protein was stored in ZBA containing 1 mM TCEP at 4°C until use.
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(a)

(b)

Figure 3.1
Digestion gel of plasmid DNA (pUCSp_SEB400, pUC57_SEB435, and
pMAL_full-β-lactamase). (a) Image of digestion gel after double-digestion at the
BamHI and HindIII sites of pUCSp_SEB400 (b) Image of digestion gel after
double-digestion at the BamHI and HindIII sites of pUC57_SEB435 (Lane 2,3)
and pMAL_full-β-lactamase (Lane 5,6). The first lane on every image of gel is 1
kb DNA ladder and legend is in unit of kilobases (kb).
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Figure 3.2
Colony PCR gel images of pMAL_SEB400 (Lane 1, 2, and 4) and
pMAL_SEB435 (Lane 5-8). The first lane on the image of gel is a 1 kb DNA
ladder and the legend is in unit of kilobases (kb). C stands for the control which
is pMAL_full-β-lactamase.

25

(a)

(a)

Figure 3.3
SDS-PAGE gels of ZFPs of stx2_233 (a) and stx2_268 (b).The size of ZFP
stx2_233 and stx2_268 is 65kDa (44 kDa MBD + 21 kDa ZFP). SN;
supernantant, FT; flow-through, W1; wash1, W2; wash2, 1~5; fraction1~5. The
legends are in unit of kilo Dalton (kDa).
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(a)

(b)

Figure 3.4
SDS-PAGE gels of ZFPs of SEB400 (a) and SEB435 (b). The size of ZFP
SEB400 and SEB435 is 65kDa (44 kDa MBD + 21 kDa ZFP).SN;
supernantant, FT;flow-through, W1;wash1, W2;wash2, 1~5;fraction1~5. The
legends are in unit of kilo Dalton (kDa).
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2. Quantification of double-stranded DNA bindingaffinity of engineered
ZFPs with Electrophoretic Mobility Shift Assay (EMSA)

Electrophoretic Mobility Shift Assay (EMSA) is a quantitative method to
determine the binding affinity of ZFPs. Kd values of a ZFP in each pair were
measured and compared to each other. To investigate how differently the
capture and detection probes would affect the sensitivity and specificity of our
system, two pairs of ZFPs were designed to recognize seb gene and stx 2 gene
coding for staphylococcal enterotoxin B (SEB) and shiga toxin (Stx2),
respectively released by S. aureus and E. coli O157 and EMSA was performed
on both of these two pairs of ZFPs. Figure 4.1 shows EMSA results of ZFPs
targeting sequence from 233 to 268 within stx 2 gene. As shown in Figure 4.1,
Kd value of ZFP stx2_268 is 1.98 nM which is lower than that of ZFP stx2_233
3.56 nM. Based on Kd values indicating binding affinity of ZFPs to their target
DNA, ZFP stx2_268 binds to its target DNA tightly, allowing for a capture probe
and ZFP stx2_233 with the higher Kd works as a detection probe which was
chemically conjugated to biotin. The Kd values of the other pairs of ZFPs
stx2_525 and 560, and stx2_1093 and 1128 were also determined. DNA binding
affinity of ZFPs SEB400 and 435 was determined by EMSA (Figure 4.2). Based
on the Kd values, ZFP stx2_233, stx2_268, SEB400, and SEB435 were chosen
for further experiments.
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(a)

(d)

(b)

(e)

(c)

(f)

Figure 4.1
Illustration of EMSA results of ZFPs designed to target different sequences
within stx2 gene. (a) Image showing Kd value of ZFP stx2_233. Top bands
indicate ZFP-DNA complex with starting protein concentration of 20 nM diluted
in ratio of 3:4. The bottom bands show only free DNA. Kd value of ZFP
stx2_233 was determined to be 3.6 nM (b) Kd value of ZFP stx2_268 was
determined to be 1.98 nM which is an average value of protein concentration of
2.3 nM and 1.7 nM. (c), (d) Kd values of ZFP stx2_525 and stx2_560 were
determined to be 200 nM and 4.5 nM, respectively. (e),(f) Kd values of ZFP
stx2_1093 and stx2_1128 were determined to be 65.7 nM and 44.9 nM,
respectively.
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(a)

(b)

Figure 4.2
Illustration of Electrophoretic Mobility Shift Assay (EMSA) results of ZFPs
designed to target different sequences within seb gene respectively. (a),(b) Kd
values of ZFP SEB400 (a) and SEB435 (b) were determined to be2.3 nM and 0.3
nM, respectively Top bands indicate ZFP-DNA complex with starting protein
concentration of 200 nM diluted in ratio of 1:2. The bottom bands show only free
DNA species
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3. Chemiluminescent detection of pathogenic dsDNA with ZFPs

Previously, we developed a colorimetric detection system where ZFPs
with SEER-LAC were immobilized on a cyclic olefin co-polymer (COC) chip. The
limit of detection was determined to be 1 nM using this system. Double-stranded
DNA detection assays based on a chemiluminescent system could lower the
limit of detection. Thus, we compared our chemiluminescent system to the
colorimetric detection system. We evaluated our engineered ZFPs targeting two
different pathogenic stx2 and seb genes with a chemiluminescent system,
aiming at improving the sensitivity. Figure 5.1 illustrates our system for
pathogenic DNA detection. The sensitivity in ZFP-based detection system could
be improved by depending on a signalling label. To attach a signaling label to
our system, the detection probe ZFP (B) was chemically conjugated with biotin
which has a strong affinity toward streptavidin (SA). SA-HRP conjugate was
applied

to

our

detection

system.

Figure

5.2

shows

results

of

the

chemiluminescent assay with the ZFP pair targeting sequence from 400 to 435
within the seb gene. The limit of detection was determined to be 0.5 nM. As
shown in Figure 5.2 (a), a DNA-dose dependent response was linear and
quantitative in the range of 0.5 nM to 50 nM (R2 correlation coefficient value of
0.94). We immobilized different amounts of ZFP SEB400 and 435 on a
nitrocellulose membrane to capture and detect target DNA. Figure.5.2 (b) shows
that target DNA was detected, with an increasing concentration of the
immobilized ZFP capturing linearly more of the target DNA.
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Figure 5.1
Schematic representation of chemiluminescent detection of target doublestranded DNA using engineered ZFPs chemically conjugated with biotin.
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(a)

(b)

Figure 5.2
Sensitivity

of

engineered

ZFPs

(SEB400

and

SEB435)

with

the

chemiluminescent detection system. (a) Image of a chemiluminescent assay
with a ZFP pair of SEB400 and biotinlyated SEB435 and the DNA dosedependent curve. (b) Image of chemiluminescent assay with a ZFP pair of
SEB400 and biotinlyated SEB435 in varying concentrations of ZFP and the
protein-concentration-dependent curve. Assay was performed in triplet and the
chemiluminescence transduced from each dot was captured by a ChargeCoupled Device (CCD) camera. Intensity of each dot on the image was
quantified by the NIH Image J program.
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(a)

(b)

Figure 5.3
Sensitivity of engineered ZFPs (Stx2_233 and Stx2_268) with chemiluminescent
detection system. (a) Image of a chemiluminescent assay with a ZFP pair of
stx2_268 and biotinlyated stx2_233 and DNA dose- dependent curve. (b) Image
of a chemiluminescent assay with a ZFP pair of stx2_268 and biotinlyated
stx2_233 in varying concentrations of ZFP and the protein-concentrationdependent curve. Assay was performed in triplet and chemiluminescence
transduced from each dot was captured by a Charge-Coupled Device (CCD)
camera. Intensity of each dot on the image was quantified by the NIH Image J
program.
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To develop this system as a point-of-care (POC) device in future, we
examined the qualitative aspects of our chemiluminescent system (Figure 5.1).
DNA binding specificity of the engineered ZFPs was examined. We immobilized
the ZFP capture probes SEB400 and stx2_268 on a nitrocellulose membrane.
Each capture probe was incubated with its own target DNA and non-target DNA.
As shown in Figure 5.4 (a), signal intensity was observed only where the ZFPs
were incubated with their own target DNA. Thus, each pair of the ZFPs was able
to distinguish its own target DNA from the non-target DNA, showing high
specificity. To demonstrate multiplexed detection, we applied a mixture of two
target DNA oligos (SEB400_435 and stx2_233_268) onto our system with each
pair of ZFPs immobilized. Incubation of a mixture of target DNA oligos showed
high signal intensity at spots where either of the two ZFPs was immobilized
(Figure 5.4 (b)). Each pair of the ZFPs bound to its own target DNA in the
presence of non- target DNA oligos. This result suggests that the engineered
ZFP pairs can be used for multiplexed detection of different pathogens.
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(a)

(b)
ZFP

SEB400, 435

stx2_233, 268

Figure 5.4
Target DNA-binding specificity test and multiplexed detection (a) Specificity test
with two pairs of ZFPs (SEB400, 435 and stx2_233, 268). (b) Multiplexed
detection system of pathogenic DNA using immobilized ZFPs SEB400&435 and
stx2_233&268. A mixture of target DNA oligos for the two ZFP pairs were
applied to each immobilized ZFP. Assay was performed in triplet and
chemiluminescence transduced from each dot was captured by a ChargeCoupled Device (CCD) camera. Intensity of each dot on the image was
quantified by the NIH Image J program.
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CONCLUSION
Discovery of DNA-binding motifs found in eukaryotic transcription factors
broadened the diversity of effective DNA detection methodologies. Among a
number of DNA-binding domains, their simple and modular structure and the
wide variety of DNA sequences they can recognize makes ZFPs an attractive
framework for attempts to engineer novel DNA- binding proteins 3. Other nucleic
acid detection systems are mostly based on amplification of target sequences,
which is considered to be time- consuming 8. Since most diagnostics require a
multiplexed and sensitive detection, due to limited test sample source, ZFPs
which can be engineered to bind numerous DNA target sequence by modular
assembly have the potential to be widely implemented for disease diagnostics
29.

This work is focused on improving the sensitivity from the previous

colorimetric target DNA system, SEER-LAC. By applying a chemiluminescent
detection system, we achieved a lowering of the limit of detection from 1 nM to
0.5 nM with a DNA-dose dependent response. More effort could be taken to
further improve the sensitivity of our detection system.
Here, we demonstrated multiplexed detection of pathogenic DNA using
engineered ZFPs in chemiluminescent detection system. In future direction, we
plan to apply alkaline phosphatase (AP) in a sandwich-type assay with ZFPs
and biotin tag to compare performance of different enzyme domains.
Designing ZFPs with different chemiluminescent tags can broaden the potential
of our system to improve sensitivity with a rapid detection.
As we focused on developing our system to be implemented as a point37

of-care (POC) testing, we could further develop multiplexed biomedical
detection platform using bacterial cells or blood. Since blood and urine are
composed of complex biological materials, we need to develop an appropriate
sample treatment method, which enables our system to detect pathogenic DNA
in the presence of complex genome and other components of cells. Although we
were able to achieve limit of detection of 0.5 nM, our system could be further
tested with cell lysate containing target DNA.
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